Like a clump of Scotch broom sprouting each year on Oregon hillsides no matter how many times it gets pulled, the pharmaceutical companies are repeating their efforts from past sessions to restrict the ability of pharmacists to dispense generic or “biosimilar” alternatives to so-called biological
The amendment that would restrict pharmacists from dispensing generic insulin slipped out of the Capitol in the same way it appeared -- quietly, in an irregular committee at an odd hour.
The Joint Capital Construction budget subcommittee voted to delete the amendment from House Bill 4110 at its 7:45 p.m. meeting on Wednesday. The full Ways & Means Committee approved HB 4110 without the amendment at its 8 p.m. meeting on Thursday.
House Majority Leader Val Hoyle, D-Eugene, has slipped an amendment for pharmaceutical giant Eli Lilly into an unrelated healthcare bill that will protect its patented insulin drug against generic competition while Eli L